Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Stage I Triple-Negative Breast Cancer: Moving From One-Size-Fits-All to a Personalized Approach.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 24, 2026
Personalizing Curative Therapy in Stage II to III Triple-Negative Breast Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 16, 2026
Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: April 10, 2026
ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Journal: Annals of surgical oncology
Published: March 12, 2026
Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.
Journal: Breast cancer research and treatment
Published: March 11, 2026
GLP-1 Targeting Agents Impair Chemoimmunotherapy Effectiveness in Triple-Negative Breast Cancer.
Journal: Research square
Published: January 16, 2026
OPERA-01: a phase III study of palazestrant for ER+, HER2- advanced breast cancer after CDK4/6 inhibitor therapy.
Journal: Future oncology (London, England)
Published: December 29, 2025
Preoperative MRI versus Ultrasound in Axillary Nodal Staging in Breast Cancer: Additive Role of MRI.
Preoperative MRI versus Ultrasound in Axillary Nodal Staging in Breast Cancer: Additive Role of MRI.
Journal: Journal of breast imaging
Published: November 30, 2025
Ablative Preoperative Single-Fraction Radiation Dose Escalation Among Patients With Breast Cancer: A Phase 1 Nonrandomized Clinical Trial.
Journal: JAMA network open
Published: November 14, 2025
Plain language summary of publication: Comparing nivolumab and neoadjuvant chemotherapy with placebo and neoadjuvant chemotherapy in participants with newly diagnosed estrogen receptor-positive breast cancer in the CheckMate 7FL clinical trial.
Journal: Future oncology (London, England)
Published: October 08, 2025
Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
Journal: Annals of surgical oncology
Published: October 03, 2025
Last Updated: 09/26/2026